Drug
Sublocade
Sublocade: highest development phase Post-Market, developed by Indivior. 2 trial records tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Indivior
Trials
| Drug | Phase | Indication |
|---|---|---|
| Sublocade NCT04060654 | Post-Market | Opioid Use Disorder, Severe |
| SUBLOCADE NCT03818399 | Phase 3 | Opioid Use Disorder |
Latest
No recent events.
Follow Sublocade on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.